rc 3095 has been researched along with Colorectal Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dal Pizzol, F; Di Leone, LP; Roesler, R; Schwartsmann, G | 1 |
1 other study(ies) available for rc 3095 and Colorectal Cancer
| Article | Year |
|---|---|
MAPK pathway activation in colorectal cancer: a therapeutic opportunity for GRP receptor antagonists.
Topics: Animals; Antineoplastic Agents; Bombesin; Colorectal Neoplasms; Drug Delivery Systems; Humans; MAP Kinase Signaling System; Peptide Fragments; Rats; Receptors, Bombesin | 2005 |